The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer

Colorectal Disease

Volumn 11, Issue 3, 2009, Pages 254-258

  Berho, M ^a   Oviedo, M ^c   Stone, E ^b   Chen, C ^b   Nogueras, J ^c   Weiss, E ^c   Sands, D ^c   Wexner, Steven D ^b,c  

^a Departments of Pathology   (United States)

^b Department of Colorectal Surgery ^*  (United States)

^c DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Chemotherapy; Lymph nodes; Radiation therapy; Rectal cancer; Rectal carcinoma

Indexed keywords

FLUOROURACIL;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG RESPONSE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECTUM CANCER; RECTUM RESECTION; SEX DIFFERENCE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLECTOMY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 60549087565     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01597.x     Document Type: Article

References (36)

1. SEER Cancer Statistics Review 1975-2004. National Cancer Institute, Bethesda, MD.
2. Marsh PJ, James RD, Schofield PF. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective randomized study. Dis Colon Rectum 1994; 37: 1205-14.
3. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996; 348: 1605-10.
4. Wagman R, Minsky BD, Cohen AM et al. Sphincter preservation in rectal cancer with preoperative radiotherapy and coloanal anastomosis: Long term follow up. Int J Radiat Oncol Biol Phys 1998; 42: 51-57.
5. Allal AS, Bieri S, Pelloni A et al. Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: Feasibility, oncologic results and quality of life outcomes. Br J Cancer 2000; 82: 1131-8.
6. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-7.
7. Colorectal cancer collaborative group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8057 patients from 22 randomized trials. Lancet 2001; 358: 1291-7.
8. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al. Preoperative radiotherapy for resectable rectal cancer. N Engl J Med 2001; 45: 38-46.
9. Camma C, Giunta M, Fiorica F et al. Preoperative radiotherapy for respectable rectal cancer: A meta analysis. JAMA 2000; 284: 1008-15.
10. Meagher AP. Radiotherapy for rectal cancer. N Engl J Med 2002; 345: 137-42.
11. Ruo L, Tickoo S, Klimstra DS et al. Long term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002; 236: 75-81.
12. Medich D, McGinty J, Parda D et al. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma. Dis Colon Rectum 2001; 44: 1123-8.
13. Mohiuddin M, Hayne M, Regine WF et al. Prognostic significance of of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000; 48: 1075-80.
14. Janjan NA, Crane C, Feig BW et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001; 24: 107-12.
15. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS. T-level downstaging and complete pathological response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved survival. Dis Colon Rectum 2002; 45 (7): 895-903.
16. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. In T Colorect Dis 1997; 12: 19-23.
17. Kaminsky-Forrett MC, Cnroy T, Luporsi E et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 935-41.
18. Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P et al. A pathological complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46: 298-304.
19. Bouzourene H, Bosman FT, Seelentag W et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002; 94: 1121-30.
20. Losi L, Luppi G, Gavioli M et al. Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy. Int J Colorectal Dis 2006; 21: 646-51.
21. Read TE, Andujar JE, Caushaj PF. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 2004; 47: 825-31.
22. Stipa F, Zernecke A, Moore HG et al. Residual mesorectal lymph node involvement following neoadjuvant combined modality therapy: Rationale for radical resection? Ann Surg Oncol 2004; 11: 187-91.
23. Kim DW, Kim DY, Kim TH et al. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer 2006; 106: 1694-700.
24. Zmora O, Dasailva GM, Gurland B et al. Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy. Dis Colon Rectum 2004; 47: 1607-12.
25. Vecchio FM, Valentini V, Minsky BD et al. The relationship of pathological tumor regression (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 62: 752-60.
26. Tepper JE, O'Connell MJ, Niedzwiecki D et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001; 19: 157-63.
27. Beresford M, Glynned-Jones R, Richman P et al. The reliability of lymph node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol 2005; 17: 448-55.
28. Wichmann MW, Muller C, Meyer G et al. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 2002; 137: 206-10.
29. Wheeler JMD, Warren BF, Mortensen NJ et al. Quantification of histologic regression of rectal cancer after irradiation: A proposal for a modified staging system. Dis Colon Rectum 2002; 45: 1051-6.
30. Rinkus KM, Russell GB, Levine EA et al. Prognostic significance of nodal disease following preoperative radiation for rectal adenocarcinoma. Ann Surg 2002; 68: 482-7.
31. Napoleon B, Pujol B, Berger F et al. Accuracy of endosonography in the staging of rectal cancer treated by radiotherapy. Br J Surg 1991; 78: 785-8.
32. Meterissian S, Skibber J, Rich T et al. Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma. Ann Surg Oncol 1994; 1: 111-6.
33. Spitz FR, Giacco GC, Hess K et al. p53 immunohistochemical staining predicts residual disease in patients with high risk rectal cancer. Clin Cancer Res 1997; 3: 1685-90.
34. Berger C, De Muret A, Garaud P et al. Preoperative radiotherapy (RT) for rectal cancer. Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications. Int J Radiat Oncol Biol Phys 1997; 37: 619-27.
35. Francois Y, Nemoz CJ, Baulieux J et al. Influence of the interval between properative radiation therapy and surgery on downstaging and on the rate of sphincter sparing surgery for rectal cancer: The Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396.
36. Mandard AM, Dalibard F, Mandard JC et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-6.